(Q37972706)

26 August 2017

title

Molecular genetics of prostate cancer: emerging appreciation of genetic complexity (English)

1 reference

26 August 2017

1 reference

1 reference

3

1 reference

26 August 2017

Christopher E. Barbieri

object named as

Christopher E Barbieri

series ordinal

1

0 references

Francesca Demichelis

object named as

Francesca Demichelis

series ordinal

2

0 references

publication date

1 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

60

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

187-198

1 reference

Common gene rearrangements in prostate cancer

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Distinct genomic aberrations associated with ERG rearranged prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Therapeutic targeting of SPINK1-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Diverse somatic mutation patterns and pathway alterations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

The genomic complexity of primary human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

E17K substitution in AKT1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Accurate whole human genome sequencing using reversible terminator chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Accurate multiplex polony sequencing of an evolved bacterial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Rapid whole-genome mutational profiling using next-generation sequencing technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Recurrent gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Transcriptome sequencing to detect gene fusions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Implications of chimaeric non-co-linear transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

FusionSeq: a modular framework for finding gene fusions by analyzing Paired-End RNA-Sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Assessing individual risk for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

ETS gene fusions in prostate cancer: from discovery to daily clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Antibody-based detection of ERG rearrangement-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

PCA3: a molecular urine assay for predicting prostate biopsy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Human tMDC III: a sperm protein with a potential role in oocyte recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

The ADAMs: signalling scissors in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Structure and mechanism of the Hsp90 molecular chaperone machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

The Hsp90 molecular chaperone: an open and shut case for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Induced chromosomal proximity and gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Identification of a novel nuclear speckle-type protein, SPOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

A common variant associated with prostate cancer in European and African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Multiple newly identified loci associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Multiple loci identified in a genome-wide association study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Prostate cancer susceptibility variants confer increased risk of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Association of megalin genetic polymorphisms with prostate cancer risk and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Vitamin D pathway gene variants and prostate cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

CYP17 polymorphisms and prostate cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Susceptibility loci associated with prostate cancer progression and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Structural variants: changing the landscape of chromosomes and design of disease studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Copy number variation: new insights in genome diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Global variation in copy number in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Integrated detection and population-genetic analysis of SNPs and copy number variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Structural variation in the human genome and its role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Copy number variation in human health, disease, and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

A computational framework discovers new copy number variants with functional importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Origins and functional impact of copy number variation in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Mapping copy number variation by population-scale genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Relative impact of nucleotide and copy number variation on gene expression phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Copy number variation at 1q21.1 associated with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

The current excitement about copy-number variation: how it relates to gene duplications and protein families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04041.X

10.1111/J.1365-2559.2011.04041.X

21 January 2018

Identifiers

DOI

1 reference

release_jojjd6rp4jfalpdfbufloyj66i

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jojjd6rp4jfalpdfbufloyj66i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference